Bringing together biological relevance, experimental flexibility, and practical usability for drug discovery, dermatology, and cosmetic science.
As the demand for more predictive, human-relevant research models continues to grow, scientists are increasingly looking beyond traditional cell cultures and animal models for answers. Researchers need skin models that not only replicate the structure of human tissue but also provide meaningful, translatable insights that help de-risk development programmes earlier.
REPROSKIN™ has been developed to meet that challenge.
Built using primary human skin cells and proprietary Alvetex® scaffold technology, REPROSKIN™ provides a biologically relevant 3D human skin model that closely mirrors native human tissue while offering the flexibility required for a wide range of commercial research applications. The platform is now available both as a fully characterised research product and as a custom research service, giving organisations the freedom to integrate REPROSKIN™ into their workflows in the way that best suits their needs.
Why REPROSKIN™?
Unlike many reconstructed skin models that rely heavily on synthetic components or simplified tissue structures, REPROSKIN™ has been designed to more accurately reflect the architecture and biology of native human skin.
The model incorporates primary human dermal fibroblasts and keratinocytes, creating physiologically relevant tissue compartments that resemble those found in vivo. Importantly, dermal fibroblasts generate their own endogenous extracellular matrix (ECM), reducing dependence on animal-derived or synthetic materials and creating a tissue environment that is more representative of human skin. These features were highlighted by Jessica Simpson as key advantages of the platform.
Using Alvetex® Scaffold technology, REPROSKIN™ develops distinct dermal and epidermal layers separated by an ECM-rich basement membrane. The resulting tissue demonstrates characteristic epidermal differentiation and barrier-associated marker expression consistent with native human skin and forms a fully differentiated stratum corneum that supports transepidermal water loss (TEWL) measurements.
The result is a versatile in vitro skin platform that enables researchers to investigate biological responses in a more physiologically relevant context.
More Than a Skin Model: A Platform for Discovery
One of the biggest strengths of REPROSKIN™ is its adaptability.
Researchers can perform a variety of clinically relevant manipulations, including tape stripping, surface occlusion, shaving, and wound-healing studies. The tissue is also compatible with topical dosing approaches, making it highly suitable for evaluating therapeutic compounds, dermatological formulations, cosmetic ingredients, and medical device applications.
The platform has been specifically developed to allow easy access to the epidermal surface through novel Alvetex® inserts, simplifying compound application and experimental workflows.
Furthermore, REPROSKIN™ supports a broad range of analytical techniques, including:
- Histology and morphological assessment
- Immunohistochemistry and immunofluorescence staining
- RNA extraction and gene expression analysis
- Protein extraction and biomarker evaluation
- Barrier integrity measurements, including TEWL
- Multiple assay endpoints from a single tissue construct through post-culture dissection
This flexibility allows researchers to maximise the amount of data obtained from every study while reducing experimental complexity.
Available as a Product
For organisations with established in-house capabilities, REPROSKIN™ can be supplied as a ready-to-use research product.
This option provides scientists with direct access to a high-quality, reproducible human skin model that can be incorporated into existing screening, formulation, and mechanistic research programmes.
The service also allows the biological complexity of the model to be tailored to the research question. Additional cell types, such as macrophages, Langerhans cells or melanocytes, can be incorporated where required, while adult cells may be used in place of neonatal cells to create models that better reflect mature or age-relevant skin biology.
Potential applications include:
Dermatology Drug Discovery
Evaluate therapeutic candidates for inflammatory skin diseases such as psoriasis, atopic dermatitis, acne, and other dermatological conditions using a human-relevant tissue platform.
Cosmetic and Personal Care Testing
Assess ingredient performance, efficacy, irritation potential, and barrier effects in a model that more closely resembles native human skin than traditional monolayer cultures.
Topical Formulation Development
Investigate formulation performance, penetration strategies, and biological responses following topical application.
Wound Healing Research
Study tissue regeneration, repair mechanisms, and treatment effects using controlled wound models.
Barrier Function Studies
Measure and monitor skin barrier integrity and recovery through clinically relevant endpoints including TEWL.
Available as a Custom Research Service
Not every organisation has the infrastructure or expertise required to perform advanced tissue culture studies internally.
For these groups, REPROCELL offers REPROSKIN™ as a complete contract research service, enabling clients to access the technology alongside scientific expertise and customised study design.
Our scientists can work with clients to design and execute studies tailored to specific development objectives, from early proof-of-concept investigations through to more advanced mechanistic programmes.
Service-based applications include:
Efficacy Testing
Evaluate biological activity and treatment responses in a controlled human tissue environment.
Mechanism of Action Studies
Investigate molecular pathways and biological responses to better understand how candidate compounds exert their effects.
Biomarker Analysis
Generate translational data through gene, protein, and histological endpoints.
Comparative Product Testing
Compare formulations, active ingredients, or treatment approaches across multiple experimental conditions.
Bespoke Study Design
Develop customised protocols that address unique scientific questions while producing robust, decision-enabling data.
Supporting the Shift Towards Human-Relevant Research
Drug developers, biotechnology companies, cosmetic manufacturers, and academic researchers are all under increasing pressure to generate data that better predicts human outcomes.
REPROSKIN™ has been developed to help meet that need.
By combining physiologically relevant tissue architecture, endogenous matrix generation, flexible experimental design, and comprehensive downstream analysis capabilities, REPROSkin™ provides researchers with a powerful platform for understanding skin biology and evaluating new therapies, formulations, and technologies.
Whether you choose to purchase REPROSKIN™ as a research product or leverage the expertise of our scientists through a customised service programme, the goal remains the same: generating robust, human-relevant data that supports better research decisions.
Discover REPROSKIN™
Interested in learning how REPROSKIN™ could support your next dermatology, cosmetic, or topical drug development programme? Contact the REPROCELL team to discuss your research objectives and explore how this next-generation human skin platform can accelerate your path to meaningful results.
